buthionine sulfoximine has been researched along with Rhabdoid Tumor in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hannon Barroeta, P; O'Sullivan, MJ; Zisterer, DM | 1 |
1 other study(ies) available for buthionine sulfoximine and Rhabdoid Tumor
| Article | Year |
|---|---|
The role of the Nrf2/GSH antioxidant system in cisplatin resistance in malignant rhabdoid tumours.
Topics: Antioxidants; Apoptosis; Buthionine Sulfoximine; Cell Line, Tumor; Child; Cisplatin; Glutathione; Humans; NF-E2-Related Factor 2; Reactive Oxygen Species; Rhabdoid Tumor | 2023 |